Antisense phosphorothioate oligonucleotide inhibits interleukin 1β production in the human macrophage-like cell line, U937

Antisense and Nucleic Acid Drug Development

Volumn 6, Issue 1, 1996, Pages 55-61

  Yahata, Naokazu ^a,b   Kawai, Shinichi ^a   Higaki, Megumu ^a   Mizushima, Yutaka ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b MEIJI SEIKA KAISHA LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; INTERLEUKIN 1BETA; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG UPTAKE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MACROPHAGE; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION;

EID: 0029895114     PISSN: 10872906     EISSN: None     Source Type: Journal    
DOI: 10.1089/oli.1.1996.6.55     Document Type: Article

References (22)

1. AKHTAR, S., and JULIANO, R.L. (1992). Liposome delivery of antisense oligonucleotides: Adsorption and efflux characteristics of phosphorothioate oligodeoxynucleotides. J. Cont. Rel. 22, 47-56.
2. CASTOR, C.W. (1993). Regulation of connective tissue metabolism. In: Arthritis and Allied Conditions, 12th ed. D.J. McCarty and W.J. Koopman, eds. (Lea & Febiger, Philadelphia), pp. 245-262.
3. CHIANG, M.-Y., CHAN, H., ZOUNES, M.A., FREIER, S.M., LIMA, W.F., and BENNETT, C.F. (1991). Antisense oligonucleotides inhibit intercellular adhesion molecule 1 expression by two distinct mechanisms. J. Biol. Chem. 266, 18162-18171.
4. DINARELLO, C.A., and WOLFF, S.M. (1993). The role of interleukin 1 in disease. N. Engl. J. Med. 328, 106-113.
5. DOLNICK, B.J. (1990). Antisense agents in pharmacology. Biochem. Pharmacol. 40, 671-675.
6. ESTROV, Z., KURZROCK, R., WETZLER, M., KANTARJIAN, H., BLAKE, M., HARRIS, D., GUTTERMAN, J.U., and TALPAZ, M. (1991). Suppression of chronic myelogenous leukemia colony growth by interleukin 1 (IL-1) receptor antagonist and soluble IL-1 receptor: A novel application for inhibitors of IL-1 activity. Blood 78, 1476-1484.
7. FANSLOW, W.C., SIMS, J.E., SASSENFELD, H., MORRISSEY, P.J., GILLIS, S., DOWER, S.K., and WIDMER, M.B. (1990). Regulation of alloreactivity in vivo by a soluble form of the interleukin 1 receptor. Science 248, 739-742.
8. GRANOWITZ, E.V., PORAT, R., MIER, J.W., PRIBBLE, J.P., STILES, D.M., BLOEDOW, D.C., CATALANO, M.A., WOLFF, S.M., and DINARELLO, C.A. (1992). Pharmacokinetics, safety and immunomodulatory effects of human recombinant interleukin 1 receptor antagonist in healthy humans. Cytokine 4, 353-360.
9. HÉLÈNE, C., and TOULMÉ, J.J. (1990). Specific regulation of gene expression by antisense, sense and antigene nucleic acids. Biochim. Biophys. Acta 1049, 99-125.
10. HO, P.T.C., ISHIGURO, K., WICKSTROM, E., and SARTORELLI, A.C. (1991). Non-sequence-specific inhibition of transferrin receptor expression in HL-60 leukemia cells by phosphorothioate oligodeoxynucleotides. Antisense Res. Dev. 1, 329-342.
11. LEMAY, L.G,. OTTERNESS, I.G., VANDER, A.J., and KLUGER, M.J. (1990). In vivo evidence that the rise in plasma IL-6 following injection of a fever-inducing dose of LPS is mediated by IL-1β. Cytokine 2, 199-204.
12. MANSON, J., BROWN, T., and DUFF, G. (1990). Modulation of interleukin 1β gene expression using antisense phosphorothioate oligonucleotides. Lymphokine Res. 9, 35-42.
13. MATSUKURA, M., ZON, G., SHINOZUKA, K., ROBERT-GUROFF, M., SHIMADA, T., STEIN, C.A., MITSUYA, H., WONG-STAAL, F., COHEN, J.S., and BRODER, S. (1989). Regulation of viral expression of human immunodeficiency virus in vitro by an antisense phosphorothioate oligodeoxynucleotide against rev (art/trs) in chronically infected cells. Proc. Natl. Acad. Sci. USA 86, 4244-4248.
14. NISHIDA, T., NISHINO, N., TAKANO, M., KAWAI, K., BANDO, K., MASUI, Y., NAKAI, S., and HIRAI, Y. (1987). cDNA cloning of IL-1α and IL-1β from mRNA of U937 cell line. Biochem. Biophys. Res. Commun. 143, 345-352.
15. STEIN, C.A., and CHENG, Y-C. (1993). Antisense oligonucleotides as therapeutic agents: Is the bullet really magical? Science 261, 1004-1012.
16. STEIN, C.A., MORI, K., LOKE, S.L., SUBASINGHE, C., SHINOZUKA, K., COHEN, J.S., and NECKERS, L.M. (1988). Phosphorothioate and normal oligodeoxyribonucleotides with 5′-linked acridine: characterization and preliminary kinetics of cellular uptake. Gene 72, 333-341.
17. SUNDSTRÖM, C., and NILSSON, K. (1976). Establishment and characterization of a human histiocytic lymphoma cell line (U937). Int. J. Cancer 17, 565-577.
18. TANIHARA, M., SUZUKI, Y., FUJIWARA, C., ABE, C., ABE, E., SUDA, T., and MIZUSHIMA, Y. (1992). A synthetic peptide corresponding to 86-93 of the human type 1 IL-1 receptor binds human recombinant IL-1 (α and β) and inhibits IL-1 actions in vitro and in vivo. Biochem. Biophys. Res. Commun. 188, 912-920.
19. WAGNER, R.W. (1994). Gene inhibition using antisense oligodeoxynucleotides. Nature 372, 333-335.
20. WICKSTROM, E. (1986). Oligodeoxynucleotide stability in subcellular extracts and culture media. J. Biochem. Biophys. Methods 13, 97-102.
21. YASWEN, P., STAMPFER, M.R., GHOSH, K., and COHEN, J.S. (1993). Effects of sequence of thioated oligonucleotides on cultured human mammary epithelial cells. Antisense Res. Dev. 3, 67-77.
22. ZHAO, Q., MATSON, S., HERRERA, C.J., FISHER, E., YU, H., and KRIEG, A.M. (1993). Comparison of cellular binding and uptake of antisense phosphodiester, phosphorothioate, and mixed phosphorothioate and methylphosphonate oligonucleotides. Antisense Res. Dev. 3, 53-66.